Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS
· Delayed Price · Currency is USD
0.0450
+0.0040 (9.76%)
Mar 9, 2026, 11:26 AM EST
PLSH Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -7.67 | -8.02 | -9.14 | -4.78 | -5.23 | -2.81 |
| Depreciation & Amortization | 1.67 | 1.71 | 1.73 | 1.74 | 1.69 | 0.79 |
| Other Amortization | - | 0.04 | 1.07 | 0.12 | - | - |
| Loss (Gain) From Sale of Assets | - | - | - | 0.3 | 0.14 | 0.49 |
| Loss (Gain) From Sale of Investments | 0.92 | 1.09 | 2.64 | -1.17 | -1.43 | -0.13 |
| Other Operating Activities | 0.61 | 0.61 | -0.25 | -0.76 | - | -0.23 |
| Change in Accounts Receivable | 0.49 | 0.43 | 0.04 | -0.1 | 0.15 | -0.15 |
| Change in Inventory | -0.11 | 0.3 | -0.18 | -0.55 | -5.05 | -2.92 |
| Change in Accounts Payable | 2.14 | 1.99 | 1.08 | 1.07 | 0.65 | 0.81 |
| Change in Other Net Operating Assets | 0.38 | 0.32 | 0.62 | 0.21 | 1.42 | 0.25 |
| Operating Cash Flow | -1.57 | -1.52 | -2.4 | -3.92 | -7.65 | -3.89 |
| Capital Expenditures | -0.06 | -0.07 | -0.24 | -0.16 | -3.2 | -6.98 |
| Sale of Property, Plant & Equipment | - | - | - | 0.45 | 0.12 | - |
| Cash Acquisitions | - | - | - | 0.01 | - | - |
| Investment in Securities | - | - | 0.05 | 0.23 | - | - |
| Investing Cash Flow | -0.06 | -0.07 | -0.2 | 0.52 | -3.08 | -6.98 |
| Short-Term Debt Issued | - | 0.29 | 0.25 | 3.55 | 6.26 | 15.73 |
| Long-Term Debt Issued | - | 1.8 | 4.09 | - | - | - |
| Total Debt Issued | 1.94 | 2.09 | 4.34 | 3.55 | 6.26 | 15.73 |
| Short-Term Debt Repaid | - | - | - | - | - | -2.58 |
| Long-Term Debt Repaid | - | -0.41 | -1.76 | -0.21 | -3.96 | - |
| Total Debt Repaid | -0.29 | -0.41 | -1.76 | -0.21 | -3.96 | -2.58 |
| Net Debt Issued (Repaid) | 1.66 | 1.68 | 2.58 | 3.33 | 2.3 | 13.16 |
| Issuance of Common Stock | - | - | - | - | - | 0.37 |
| Financing Cash Flow | 1.66 | 1.68 | 2.58 | 3.33 | 2.3 | 18.52 |
| Miscellaneous Cash Flow Adjustments | - | - | - | -0 | - | - |
| Net Cash Flow | 0.03 | 0.09 | -0.01 | -0.06 | -8.43 | 7.65 |
| Free Cash Flow | -1.62 | -1.59 | -2.64 | -4.09 | -10.85 | -10.87 |
| Free Cash Flow Margin | -58.71% | -66.66% | -162.47% | -198.34% | -120.28% | -494.42% |
| Free Cash Flow Per Share | -0.10 | -0.10 | -0.18 | -0.23 | -0.64 | -0.61 |
| Cash Interest Paid | - | - | - | - | 0.58 | - |
| Levered Free Cash Flow | -0.17 | -0.06 | -1.26 | 0.51 | -9.02 | - |
| Unlevered Free Cash Flow | 0.83 | 0.87 | -1.05 | 1.08 | -8.07 | - |
| Change in Working Capital | 2.9 | 3.03 | 1.56 | 0.63 | -2.82 | -2 |
Source: S&P Capital IQ. Standard template. Financial Sources.